You need to Turn on Javascript or upgrade your Flash Player!

To Fully experience the Rich Media Solutions of this website, you must make sure that JavaScript is enabled.
You may also need to upgrade your Flash Player.

You can upgrade your flash player by Clicking Here »


Transitioning IG Coverage to Medicare

Options in Medicare coverage can be more complicated than IG therapy, but these guidelines for individuals turning 65 can help to ensure a smooth transition.

The Current Role of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Diseases

HSCT (also known as bone marrow transplant [BMT]) is used to treat certain forms of Primary Immunodeficiency (PI), and it is becoming much more successful due to better tissue typing and matching of donors, less toxic chemotherapy, better virus detection and treatment, improved supportive care and graft-versus-host disease (GVHD) prophylaxis.

Immune Globulin: A Guide to Billing and Reimbursement

Getting reimbursed for immune globulin (IG) can be challenging and frustrating. What is required when submitting a claim may vary, but accuracy in submission is imperative.

Long-Term Effects of PIDDs

While patients are at risk for long-term complications due to primary immunodeficiencies, these can be mitigated through early diagnosis and treatment.

Diagnosing and Treating CIDP

This autoimmune disease is difficult to diagnose due to its rarity and many variants, but once it is diagnosed, there are treatment options.

Diagnosing and Treating Peripheral Neuropathy

The only way to effectively treat neuropathies is to identify which of the many different diseases is the underlying cause and then make the proper diagnosis.

Individual IG Dosing Strategies

Studies that examine the relationships between therapeutic doses of IG, trough IgG levels and infection rates shed new light on how IG replacement therapy should be prescribed for individuals.

When It Turns Out to Be Primary Immunodeficiency Disease: Benefits of Early Diagnosis

Early referrals for workup can dramatically reduce hospitalizations, permanent disability and high cost of care.

Infusion Environments: Comparing Cost, Safety and Privacy

When choosing a site of care for immune globulin therapy, each patient’s unique situation must be considered.

The State of Acquired Hemophilia

Treatment for this type of hemophilia must be individualized for each patient, but the prognosis is often good.

An Overview of Immune Globulin Dosing

How much IG to prescribe differs for each individual based on a variety of clinical and non-clinical factors, as well as physician discretion.

On- and Off-Label Uses and Clinical Trials of IG

Immune globulin (IG) is used to treat a wide range of disorders. While the most common use of IG therapy is in treating primary immune deficiencies, its efficacy in numerous other disorders is well-documented.

Understanding and Treating IG Side Effects

Knowing what side effects, from mild to serious, to expect during and after immune globulin infusions can prepare patients and their caregivers for treatment changes to mitigate their impact.

A Comparative Look at IVIG and SCIG

With the FDA approval of SCIG therapy in 2006, many patients now have the choice between SCIG and IVIG infusions. Understanding the differences between the two treatment modalities will help healthcare providers recommend the right one for their patients.

IVIG: At the Intersection of Immunology and
Clinical Research

During the past three decades, IVIG has proven an effective treatment for a wide range of autoimmune diseases, and it is now believed that IVIG may have clinical uses for a broader range of medical conditions.